Cancer Vaccine Market to Grow at 10.7% CAGR by 2030

Rise in Carcinogenic Infections Such as Human Papillomavirus (HPV), Hepatitis B Virus, and Hepatitis C Virus Contributes Toward Growth of the Cancer Vaccine Market.

According to a new research report by Next Move Strategy Consulting, the global Cancer Vaccine Market size was valued at USD 5.75 billion in 2022, and is expected to reach USD 13.4 billion by 2030, with a CAGR of 10.7% during the forecast period.

Cancer vaccines have witnessed a rapid growth in sales, owing to rise in cases of various types of cancers including breast, lung, and cervical across the globe. This is mainly attributed to rise in consumption of alcohol and smoking. For instance, in February 2022, the World Health Organization declared that almost 2.26 million cases of breast cancer were diagnosed globally in 2020.

On the contrary, longer timeline of the process hinders growth of the cancer vaccine market. However, growth in technological developments such as liquid biopsy and biomarker testing that can detect cancer at an early stage is expected to propel the market growth.

Request for a Sample PDF on the Cancer Vaccines Market

According to the report, the leading market players that manufacture cancer vaccines include Merck & Co., Inc., GlaxoSmithKline plc (GSK), BioNTech SE, Moderna, Inc., Dendreon Pharmaceuticals LLC, Amgen Inc., Dynavax Technologies Corporation, OSE Immunotherapeutics, IO Biotech A/S, Replimune Group, Inc., Bavarian Nordic A/S, Inovio Pharmaceuticals, Inc., PDS Biotechnology Corporation, Transgene SA, Nykode Therapeutics ASA, Imugene Limited, Ultimovacs ASA, Nouscom, Scancell Holdings plc, Evaxion Biotech A/S.

Key Insights from the Cancer Vaccine Market Report:

Information related to key drivers, restraints, and opportunities and their impact on the cancer vaccine market is provided in the report.
Value chain analysis in the market study provides a clear picture of the roles of stakeholders.
Share of key players in the global cancer vaccine market, along with their competitive analysis is provide in the report.

About the Author

Sikha Haritwal is an assistant manager with strong expertise in market research, data analysis, and cross-functional coordination. She plays a key role in leading complex research initiatives, strengthening analytical rigor, and enabling data-driven decision-making across teams. Known for her leadership mindset and structured problem-solving approach, she supports process improvement, enhances operational efficiency, and contributes to building scalable frameworks that drive long-term strategic outcomes and organizational effectiveness.

About the Reviewer

Supradip Baul is an accomplished business consultant and strategist with over a decade of rich experience in market intelligence, strategy, technology, and business transformation. His work has included rigorous qualitative and quantitative analysis across multiple industries, helping clients shape investment decisions and long-term roadmaps. Earlier in his career, he was associated with Gartner, where he contributed to industry-leading reports and market share analyses. He has worked with leading global companies and holds an MBA with a dual specialization in Marketing and Finance.